Cauterizing Arteries in Laparoscopic Cholecystectomy Can Be Both Unnecessary and Dangerous

Almost since the inception of laparoscopic cholecystectomy, surgeons have been employing devices that concentrate electrical or vibrational energy to heat and thereby cauterize arteries. However, for more than 7 years, Brij Agarwal, MD, MBBS, MS, and colleagues have been avoiding the use of these energy devices. Dr. Agarwal is a senior surgeon at Sir Ganga […]

Trouble in Trialville

Trouble in Trialville: Plans for Post-DES Clopidogrel Trial GetBogged Down Over Trial Design, Leadership Almost 16 months after an FDA hearing into drug-eluting stent (DES) safety emphasized the need for a randomized clinical trial to determine, once and for all, the optimal duration of clopidogrel (Plavix, Sanofi-Aventis) plus aspirin after DES implantation, researchers, government agencies, […]

Characteristics of Patients Prescribed Angiotensin-Converting Enzyme Inhibitors

Characteristics of Patients Prescribed Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, or the Combination at an Urban Medical CenterGhania Masri, MD; Kristi Bledsoe, PharmD; Carlos Palacio, MD Abstract Background: The realization that angiotensin-converting enzyme (ACE) inhibitors do not provide complete blockade of angiotensin II synthesis has resulted in an increased use of combinations of ACE inhibitors […]

Risk for Second Nonlymphoid Neoplasms in Chronic Lymphocytic Leukemia

Constantin A. Dasanu, MD, PhD; Doru T. Alexandrescu, MDAbstract Major advances have occurred in understanding the biology, immunology, and modalities of treatment of chronic lymphocytic leukemia (CLL) in the last decade. B-cell CLL is the most common type of leukemia occurring in the US and Western nations. B-cell CLL is characterized by progressive defects in […]

A treatment strategy for NSCLC

Expert OpinionNasser Hanna, MDIndiana UniversityNasser Hanna, MD, is an assistant professor at Indiana University, medical director for their Thoracic Oncology Program, and chair of the thoracic committee for the Hoosier Oncology Group. Recently, WebMD spoke with Dr Hanna about the current treatment options in previously treated NSCLC, treatment decisions in this setting, and the role […]